Blecharczyk, M. et al. 2026. Orforglipron as a Small-Molecule GLP-1 Receptor Agonist: A New Era of Incretin-Based Oral Therapy?. Quality in Sport. 56, (May 2026), 72512. DOI:https://doi.org/10.12775/QS.2026.56.72512.